(redirected from Alpha-glucosidase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Alpha-glucosidase inhibitor: thiazolidinedione
See: deterrent
References in periodicals archive ?
The alpha-glucosidase inhibitors, acarbose and miglitol, make up the latest class of drugs available to treat diabetes.
Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors.
Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.
This article will discuss the following classes of drugs: biguanides, thiazolidinedione agents (TZDs), sulfonylureas, meglinitides, glucagon-like peptide-1 (GLP-1) agonists, dipeptyl peptidase 4 (DDP-4) inhibitors, alpha-glucosidase inhibitors, amylin analogues, and insulin.
Alpha-glucosidase inhibitors (AGI): AGIs carry a low risk of hypoglycemia, therefore they should be suitable for use during Ramadan.
Other classes of glucose-lowering drugs include sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and dipeptyidyl peptidase-4 inhibitors.
The two alpha-glucosidase inhibitors acarbose (Precose) and miglitol (Glyset) delay the digestion of carbohydrates within the gastrointestinal tract, thereby reducing the rise in blood glucose following meals.
Eslami says medications that are safe and effective in treating type 2 diabetes include alpha-glucosidase inhibitors such as acarbose (Precose) or miglitol (Glyset), or meglitinides such as repaglinide (Prandin) and nateglinide (Starlix).
According to study authors, the herb seems to work similarly to oral diabetes drugs known as alpha-glucosidase inhibitors, which impede the body's absorption of carbohydrates.
Oral diabetes medications include sulfonylureas, biguanides, alpha-glucosidase inhibitors, glitazones and meglitinides.